These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 9660845)
1. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A. Voorman RL; Maio SM; Hauer MJ; Sanders PE; Payne NA; Ackland MJ Drug Metab Dispos; 1998 Jul; 26(7):631-9. PubMed ID: 9660845 [TBL] [Abstract][Full Text] [Related]
2. Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A. Voorman RL; Maio SM; Payne NA; Zhao Z; Koeplinger KA; Wang X J Pharmacol Exp Ther; 1998 Oct; 287(1):381-8. PubMed ID: 9765359 [TBL] [Abstract][Full Text] [Related]
3. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6. Voorman RL; Payne NA; Wienkers LC; Hauer MJ; Sanders PE Drug Metab Dispos; 2001 Jan; 29(1):41-7. PubMed ID: 11124228 [TBL] [Abstract][Full Text] [Related]
4. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6. Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885 [TBL] [Abstract][Full Text] [Related]
5. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone. Mutlib AE; Klein JT J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390 [TBL] [Abstract][Full Text] [Related]
6. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
7. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. Ghosal A; Satoh H; Thomas PE; Bush E; Moore D Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602 [TBL] [Abstract][Full Text] [Related]
8. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Crewe HK; Ellis SW; Lennard MS; Tucker GT Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249 [TBL] [Abstract][Full Text] [Related]
9. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of tauromustine in liver and lung microsomes from various species. Tuvesson H; Gunnarsson PO; SeidegÄrd J Xenobiotica; 1999 Aug; 29(8):783-92. PubMed ID: 10553719 [TBL] [Abstract][Full Text] [Related]
12. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. Koudriakova T; Iatsimirskaia E; Utkin I; Gangl E; Vouros P; Storozhuk E; Orza D; Marinina J; Gerber N Drug Metab Dispos; 1998 Jun; 26(6):552-61. PubMed ID: 9616191 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats. Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Fagerness PE Drug Metab Dispos; 1997 Feb; 25(2):228-42. PubMed ID: 9029054 [TBL] [Abstract][Full Text] [Related]
15. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Gallagher EP; Kunze KL; Stapleton PL; Eaton DL Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785 [TBL] [Abstract][Full Text] [Related]
16. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily. Rodrigues AD; Roberts EM; Mulford DJ; Yao Y; Ouellet D Drug Metab Dispos; 1997 May; 25(5):623-30. PubMed ID: 9152603 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes. Sams C; Mason HJ; Rawbone R Toxicol Lett; 2000 Aug; 116(3):217-21. PubMed ID: 10996483 [TBL] [Abstract][Full Text] [Related]
18. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Eberhart DC; Gemzik B; Halvorson MR; Parkinson A Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247 [TBL] [Abstract][Full Text] [Related]
19. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096 [TBL] [Abstract][Full Text] [Related]
20. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor. Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]